Medicare Enrolled
Dr. Gaston Lacayo, M.D.
Ophthalmology · Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lacayo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lacayo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lacayo
Dr. Gaston Lacayo is an ophthalmology specialist in Miami, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lacayo performed 1,316 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lacayo received a total of $12,247 from 45 pharmaceutical and/or device companies across 515 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lacayo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 1,316 Medicare services
$12,247 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 95390 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,316
Medicare services
Bottom 34% in FL for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
308 | $99 | $198 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
210 | $72 | $147 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
123 | $31 | $108 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
120 | $26 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
104 | $120 | $250 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
95 | $439 | $2,100 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
92 | $44 | $102 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
65 | $28 | $100 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
39 | $9 | $33 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
33 | $23 | $175 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
29 | $328 | $524 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
26 | $18 | $47 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
20 | $630 | $2,500 |
| Laser eye fluid drainage tract creation A laser procedure used to create drainage tracts in the iris to help fluid flow out of the eye. |
18 | $255 | $450 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
17 | $14 | $119 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
17 | $28 | $67 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.2% high complexity
18.3% medium
74.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,247
Total received (2018-2024)
Avg $1,750/year across 7 years
Top 13% in FL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
515
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,672
2023
$1,977
2022
$2,407
2021
$2,171
2020
$1,118
2019
$1,432
2018
$1,469
Payments by company (2024)
Oyster Point Pharma, Inc.
$258
Bausch & Lomb Americas Inc.
$254
ABBVIE INC.
$241
SUN PHARMACEUTICAL INDUSTRIES INC.
$172
Mallinckrodt Hospital Products Inc.
$154
Alcon Vision LLC
$154
Regeneron Healthcare Solutions, Inc.
$111
Astellas Pharma US Inc
$78
BIOTISSUE HOLDINGS INC.
$76
Harrow Eye, LLC
$65
Halozyme Inc
$46
Johnson & Johnson Surgical Vision, Inc.
$34
Dompe US, Inc.
$29
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
Oyster Point Pharma, Inc.
$1,025
Allergan, Inc.
$966
Alcon Vision LLC
$902
Aerie Pharmaceuticals, Inc.
$860
Sun Pharmaceutical Industries Inc.
$859
Novartis Pharmaceuticals Corporation
$836
ABBVIE INC.
$800
Allergan Inc.
$733
Kala Pharmaceuticals, Inc.
$670
Mallinckrodt Hospital Products Inc.
$531
Shire North American Group Inc
$393
Bausch & Lomb Americas Inc.
$384
Regeneron Healthcare Solutions, Inc.
$312
SUN PHARMACEUTICAL INDUSTRIES INC.
$249
Dompe US, Inc.
$247
Alcon Laboratories Inc
$219
Johnson & Johnson Surgical Vision, Inc.
$213
Horizon Therapeutics plc
$211
Bausch & Lomb, a division of Bausch Health US, LLC
$204
Eyevance Pharmaceuticals LLC
$159
TISSUETECH, INC.
$126
Ivantis, Inc
$113
NEW WORLD MEDICAL,INC.
$111
NovaBay Pharmaceuticals, Inc.
$110
LENSAR, Inc.
$87
Astellas Pharma US Inc
$78
BioTissue Holdings, Inc.
$77
BIOTISSUE HOLDINGS INC.
$76
TissueTech, Inc.
$74
Sight Sciences, Inc.
$71
Harrow Eye, LLC
$65
Mallinckrodt Enterprises LLC
$52
Rayner Intraocular Lenses Limited
$49
Beaver-Visitec International, Inc.
$48
Halozyme Inc
$46
Carl Zeiss Meditec, Inc.
$42
Omeros Corporation
$39
RxSight Inc
$38
EyePoint Pharmaceuticals US, Inc.
$33
Thea Pharma Inc.
$30
Dutch Ophthalmic, USA
$26
EYEVANCE PHARMACEUTICALS LLC
$24
BIOTISSUE HOLDINGS, INC.
$23
Akorn, Inc.
$19
Carl Zeiss Meditec AG
$19
Top 3 companies account for 23.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ARGOS · AcrySof IQ PanOptix · Ahmed Glaucoma Valve · Avenova · BOTOX · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Centurion · Cequa · Clareon · DEXYCU · DUREZOL · DURYSTA · EVA · EYLEA · EYLEA HD · Flarex · HYDRUS Microstent · HYLENEX RECOMBINANT · Hydrus · INVELTYS · IOLMaster 500 · IYUZEH · Izervay · LENSAR LASER SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX SM · LUMIGAN · LenSx · Luxor · MIEBO · None Specified · OMNI(R) SURGICAL SYSTEM (US) · OPMI Lumera · ORA · OXERVATE · Omidria · Oxervate · PROKERA · PROLENSA · PanOptix · Prokera · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Simbrinza · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tobradex ST · VEVYE · VUITY · VYZULTA · Whitestart Phacoemulsficiation System · XELPROS · XIIDRA · XIPERE · Zioptan · combined machine · enVista MX60 IOL · rhopressa · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
274
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL OF MIAMI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lacayo is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lacayo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lacayo performed 308 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lacayo receive payments from pharmaceutical companies?
Yes. Dr. Lacayo received a total of $12,247 from 45 companies across 515 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lacayo's costs compare to other ophthalmologists in Miami?
Dr. Lacayo's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lacayo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Miami
Browse ophthalmologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in FL
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in FL
Which FL ophthalmologists receive the most from drug and device companies.
By company
Oyster Point Pharma, Inc. Payments to Doctors
See all physicians who received payments from Oyster Point Pharma, Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Alcon Vision LLC Payments to Doctors
See all physicians who received payments from Alcon Vision LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology